Drug
Yn003
Yn003: highest development phase Phase 1, developed by Beijing Inno Medicine Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Beijing Inno Medicine Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| YN003 Injection NCT07929909 | Phase 1 | Glioma |
Latest
No recent events.
Follow Yn003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.